Latest Partnerships News

Iceni Gold has upsized its recent placement to nearly $1.76 million, securing additional funds to advance drilling and exploration at its flagship 14 Mile Well Gold Project in Western Australia.

BCAL Diagnostics is expanding access to its Avantect pancreatic and ovarian cancer blood tests across Australia through partnerships with major pathology providers. This move marks a significant step in making early cancer detection more widely available.

Eden Innovations reports robust expansion of its EdenCrete® concrete additives in North and South America, driven by new contracts with major ready-mix concrete producers. The company’s low-carbon products are gaining traction amid growing sustainability demands.

Airtasker has secured a $5 million media partnership with Nine Entertainment, aiming to accelerate its brand growth across Australia’s leading media platforms. This strategic move comes as Airtasker rides strong marketplace momentum and positions itself for the evolving AI-driven labour market.

AML3D has landed a AU$2.61 million contract to produce critical submarine components for the US Navy using its advanced 3D metal printing technology, marking a significant step in its US defence expansion.

Qoria Limited updates shareholders on its proposed merger with Aura Consolidated Group, highlighting Aura's robust financial performance and cost-saving initiatives. The merger remains unanimously recommended by Qoria's board, pending regulatory and shareholder approvals.

Nexsen Limited is advancing its rapid Group B Streptococcus test, StrepSure®, with a clear FDA submission timeline and early market entries across Asia-Pacific and emerging regions.

Sims Lifecycle Services (SLS) has emerged as a powerhouse within Sims Group, driving nearly 40% of group earnings through strategic hyperscaler partnerships and capitalising on structural shifts in the memory market.

Killi Resources has won a Queensland Government grant to co-fund drilling at its Mt Rawdon West copper-gold project, targeting a compelling porphyry system. The planned drilling aims to test significant geochemical and geophysical anomalies in the Baloo prospect.

Eve Health Group is advancing its proprietary reformulation platform with two fast-onset products launched under Australia's SAS-B pathway, targeting large underserved markets in women's and men's health. The company’s capital-light, partner-led model aims for rapid revenue growth post-ARTG registration.

Infratil has upgraded its FY27 EBITDAF guidance for CDC Data Centres to A$680-720 million, citing accelerating construction and strong demand driven by AI and hyperscale cloud growth. The company also secured A$500 million equity funding and plans a bank debt upsizing to support expansion.

Atomo Diagnostics has responded to an ASX price query following unusual trading activity, denying any undisclosed price-sensitive information while acknowledging a related FDA update involving Lumos Diagnostics.